The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 09, 2019
Filed:
Dec. 30, 2016
Applicant:
Ancureall Pharmaceutical (Shanghai) Co., Ltd., Shanghai, CN;
Inventors:
Jutong Si, Shanghai, CN;
Guan Wang, Pudong, CN;
Zhihe Yang, Pudong, CN;
Meifeng Jiang, Shanghai, CN;
Benpo Xu, Pudong, CN;
Chentao Zhou, Pudong, CN;
Assignee:
Ancureall Pharmaceutical (Shanghai) Co., Ltd., Shanghai, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); A61K 31/505 (2006.01); A61K 31/551 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 239/47 (2006.01); C07D 239/48 (2006.01); C07D 251/18 (2006.01); A61P 35/00 (2006.01); A61K 31/53 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/505 (2013.01); A61K 31/53 (2013.01); A61K 31/551 (2013.01); A61P 35/00 (2018.01); C07D 239/47 (2013.01); C07D 239/48 (2013.01); C07D 251/18 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 405/14 (2013.01);
Abstract
Disclosed in the present invention are an acrylanilide compound represented by general formula (I) and a pharmaceutically acceptable salt thereof. The acrylanilide compound and the pharmaceutically acceptable salt thereof are used for treating clinical diseases by mainly acting on EGFR family casein kinases.